Dr Giles Yeo

Giles Yeo

University position

Principal Research Associate

Dr Giles Yeo is pleased to consider applications from prospective PhD students.

Departments

Department of Clinical Biochemistry

Institutes

Institute of Metabolic Science

Email

gshy2@cam.ac.uk

Home page

http://www.mrl.ims.cam.ac.uk/researc... (personal home page)

Research Theme

Cellular and Molecular Neuroscience

Interests

I study brain control of body-weight, and currently have two main aims:

1.) To determine a role for FTO in energy balance.

SNPs in FTO are strongly associated with obesity. FTO is nutritionally regulated within the ARC, and modulating FTO expression within the hypothalamus influences food intake. We are studying the mechanisms underlying this phenomenon. We also plan to study other genes that have emerged from obesity genome-wide association studies, focusing on those that are highly expressed in the brain.

2.) Identifying new players in the hypothalamic control of food intake.

Using laser microdissection coupled with microarrays, we have identified novel nutritional regulated genes in the PVN & ARC. Some have well known roles in CNS development but have not yet been linked to control of bodyweight. We are pursuing these novel observations. In addition, as part of the EU FP7 funded grant EurOCHIP, we aim to identify molecular mechanisms underlying ghrelin’s action in the brain.

Laser captured mouse hypothalamic nuclei
Laser captured mouse hypothalamic nuclei
Click image to view full-size

Research Focus

Keywords

obesity

genetics

food intake

genomics

hypothalamus

Clinical conditions

Diabetes

Genetic disorders

Obesity

Type II Diabetes

Equipment

Bioinformatics

Cell culture

Confocal microscopy

Cross-sectional and cohort studies

Gene expression profiling

High-throughput 'next-gen' sequencing

Laser capture microdissection

Collaborators

Cambridge

Raymond Bujdoso

Anthony Coll

James Fawcett

Christine Holt

Stephen O'Rahilly

Susan Ozanne

Associated News Items


Key publications

Gulati P, Cheung MK, Antrobus R, Church CD, Harding HP, Tung YC, Rimmington D, Ma M, Ron D, Lehner PJ, Ashcroft FM, Cox RD, Coll AP, O'Rahilly S, Yeo GS (2013), “Role for the obesity-related FTO gene in the cellular sensing of amino acids.” Proc Natl Acad Sci U S A 110(7):2557-62 Details

Jovanovic Z, Tung YC, Lam BY, O'Rahilly S, Yeo GS (2010), “Identification of the global transcriptomic response of the hypothalamic arcuate nucleus to fasting and leptin.” J Neuroendocrinol 22(8):915-25 Details

Tung YC, Ayuso E, Shan X, Bosch F, O'Rahilly S, Coll AP, Yeo GS (2010), “Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats.” PLoS One 5(1):e8771 PDF Details

Tung YC, Ma M, Piper S, Coll A, O'Rahilly S, Yeo GS (2008), “Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus.” J Neurosci 28(47):12419-26 Details

Yeo GSH, Hung CC, Rochford J, Keogh JM, Gray J, Sivaramakrishnan S, O’Rahilly S, Farooqi IS (2004), “A de novo mutation affecting human TrkB associated with severe obesity and developmental delay” Nature Neuroscience 7(11):1187-9

Publications

2014

Carr SK, Chen JH, Cooper WN, Constância M, Yeo GS, Ozanne SE (2014), “Maternal diet amplifies the hepatic aging trajectory of Cidea in male mice and leads to the development of fatty liver.” FASEB J Details

Loos RJ, Yeo GS (2014), “The bigger picture of FTO--the first GWAS-identified obesity gene.” Nat Rev Endocrinol 10(1):51-61 Details

Moshayedi P, Ng G, Kwok JC, Yeo GS, Bryant CE, Fawcett JW, Franze K, Guck J (2014), “The relationship between glial cell mechanosensitivity and foreign body reactions in the central nervous system.” Biomaterials Details

2013

Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, Tops B, Küsters B, Ceral J, Yeo GS, Neogi SG, McFarlane I, Rosenfeld N, Marass F, Hadfield J, Margas W, Chaggar K, Solar M, Deinum J, Dolphin AC, Farooqi IS, Striessnig J, Nissen P, Brown MJ (2013), “Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.” Nat Genet 45(9):1055-60 Details

Cheung MK, Gulati P, O'Rahilly S, Yeo GS (2013), “FTO expression is regulated by availability of essential amino acids.” Int J Obes (Lond) 37(5):744-7 Details

Coll AP, Yeo GS (2013), “The hypothalamus and metabolism: integrating signals to control energy and glucose homeostasis.” Curr Opin Pharmacol 13(6):970-6 Details

Goodall JC, Yeo GS (2013), “PP2Ce: Fat and stressed out?” Mol Metab 2(4):325-6 Details

Gulati P, Yeo GS (2013), “The biology of FTO: from nucleic acid demethylase to amino acid sensor.” Diabetologia 56(10):2113-21 Details

McMurray F, Church CD, Larder R, Nicholson G, Wells S, Teboul L, Tung YC, Rimmington D, Bosch F, Jimenez V, Yeo GS, O'Rahilly S, Ashcroft FM, Coll AP, Cox RD (2013), “Adult onset global loss of the fto gene alters body composition and metabolism in the mouse.” PLoS Genet 9(1):e1003166 Details

2012

Chadt A, Yeo GS, Al-Hasani H (2012), “Nutrition-/diet-induced changes in gene expression in pancreatic β-cells.” Diabetes Obes Metab 14 Suppl 3:57-67 Details

Habib AM, Richards P, Cairns LS, Rogers GJ, Bannon CA, Parker HE, Morley TC, Yeo GS, Reimann F, Gribble FM (2012), “Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry.” Endocrinology 153(7):3054-65 Details

Klus P, Lam S, Lyberg D, Cheung MS, Pullan G, McFarlane I, Yeo GSh, Lam BY (2012), “BarraCUDA - a fast short read sequence aligner using graphics processing units.” BMC Res Notes 5:27 Details

Ma M, Harding HP, O'Rahilly S, Ron D, Yeo GS (2012), “Kinetic analysis of FTO (fat mass and obesity-associated) reveals that it is unlikely to function as a sensor for 2-oxoglutarate.” Biochem J 444(2):183-7 Details

Yeo GS (2012), “FTO and obesity: a problem for a billion people.” J Neuroendocrinol 24(2):393-4 Details

Yeo GS, Heisler LK (2012), “Unraveling the brain regulation of appetite: lessons from genetics.” Nat Neurosci 15(10):1343-9 Details

Yeo GS, O'Rahilly S (2012), “Uncovering the biology of FTO.” Mol Metab 1(1-2):32-6 Details

Zito E, Hansen HG, Yeo GS, Fujii J, Ron D (2012), “Endoplasmic reticulum thiol oxidase deficiency leads to ascorbic acid depletion and noncanonical scurvy in mice.” Mol Cell 48(1):39-51 Details

2011

Cheung MK, Yeo GS (2011), “FTO Biology and Obesity: Why Do a Billion of Us Weigh 3 kg More?” Front Endocrinol (Lausanne) 2:4 Details

Gumy LF, Yeo GS, Tung YC, Zivraj KH, Willis D, Coppola G, Lam BY, Twiss JL, Holt CE, Fawcett JW (2011), “Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization.” RNA 17(1):85-98 Details

Larder R, Cheung MK, Tung YC, Yeo GS, Coll AP (2011), “Where to go with FTO?” Trends Endocrinol Metab 22(2):53-9 Details

Shan X, Yeo GS (2011), “Central leptin and ghrelin signalling: comparing and contrasting their mechanisms of action in the brain.” Rev Endocr Metab Disord 12(3):197-209 Details

Stewart L, Hindmarch CC, Qiu J, Tung YC, Yeo GS, Murphy D (2011), “Hypothalamic transcriptome plasticity in two rodent species reveals divergent differential gene expression but conserved pathways.” J Neuroendocrinol 23(2):177-85 Details

Tung YC, Yeo GS (2011), “From GWAS to biology: lessons from FTO.” Ann N Y Acad Sci 1220:162-71 Details

Yeo GS (2011), “Where next for GWAS?” Brief Funct Genomics 10(2):51 Details

2010

Chen JH, Tarry-Adkins JL, Matharu K, Yeo GS, Ozanne SE (2010), “Maternal protein restriction affects gene expression profiles in the kidney at weaning with implications for the regulation of renal function and lifespan.” Clin Sci (Lond) 119(9):373-84 Details

Corander MP, Challis BG, Thompson EL, Jovanovic Z, Loraine Tung YC, Rimmington D, Huhtaniemi IT, Murphy KG, Topaloglu AK, Yeo GS, O'Rahilly S, Dhillo WS, Semple RK, Coll AP (2010), “The effects of neurokinin B upon gonadotrophin release in male rodents.” J Neuroendocrinol 22(3):181-7 Details

Dreja T, Jovanovic Z, Rasche A, Kluge R, Herwig R, Tung YC, Joost HG, Yeo GS, Al-Hasani H (2010), “Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome.” Diabetologia 53(2):309-20 Details

Jovanovic Z, Yeo GS (2010), “Central leptin signalling: beyond the arcuate nucleus.” Auton Neurosci 156(1-2):8-14 Details

Meyre D, Proulx K, Kawagoe-Takaki H, Vatin V, Gutiérrez-Aguilar R, Lyon D, Ma M, Choquet H, Horber F, Van Hul W, Van Gaal L, Balkau B, Visvikis-Siest S, Pattou F, Farooqi IS, Saudek V, O'Rahilly S, Froguel P, Sedgwick B, Yeo GS (2010), “Prevalence of loss-of-function FTO mutations in lean and obese individuals.” Diabetes 59(1):311-8 Details

Romeo S, Sentinelli F, Dash S, Yeo GS, Savage DB, Leonetti F, Capoccia D, Incani M, Maglio C, Iacovino M, O'Rahilly S, Baroni MG (2010), “Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.” Int J Obes (Lond) 34(1):190-4 Details

Tung YC, Yeo GS (2010), “Central melanocortin signaling regulates cholesterol.” Nat Neurosci 13(7):779-80 Details

Zivraj KH, Tung YC, Piper M, Gumy L, Fawcett JW, Yeo GS, Holt CE (2010), “Subcellular profiling reveals distinct and developmentally regulated repertoire of growth cone mRNAs.” J Neurosci 30(46):15464-78 Details

2009

Boissel S, Reish O, Proulx K, Kawagoe-Takaki H, Sedgwick B, Yeo GS, Meyre D, Golzio C, Molinari F, Kadhom N, Etchevers HC, Saudek V, Farooqi IS, Froguel P, Lindahl T, O'Rahilly S, Munnich A, Colleaux L (2009), “Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations.” Am J Hum Genet 85(1):106-11 Details

Dash S, Sano H, Rochford JJ, Semple RK, Yeo G, Hyden CS, Soos MA, Clark J, Rodin A, Langenberg C, Druet C, Fawcett KA, Tung YC, Wareham NJ, Barroso I, Lienhard GE, O'Rahilly S, Savage DB (2009), “A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia.” Proc Natl Acad Sci U S A 106(23):9350-5 Details

de Smith AJ, Purmann C, Walters RG, Ellis RJ, Holder SE, Van Haelst MM, Brady AF, Fairbrother UL, Dattani M, Keogh JM, Henning E, Yeo GS, O'Rahilly S, Froguel P, Farooqi IS, Blakemore AI (2009), “A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism.” Hum Mol Genet 18(17):3257-65 Details

Tan K, Pogozheva ID, Yeo GS, Hadaschik D, Keogh JM, Haskell-Leuvano C, O'Rahilly S, Mosberg HI, Farooqi IS (2009), “Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor.” Endocrinology 150(1):114-25 Details

2008

Coll AP, Yeo GS, Farooqi IS, O'Rahilly S (2008), “SnapShot: the hormonal control of food intake.” Cell 135(3):572.e1-2 Details

Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O'Rahilly S, Heisler LK (2008), “Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.” Endocrinology 149(3):1323-8 Details

2007

Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O'Rahilly S, Schofield CJ (2007), “The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.” Science 318(5855):1469-72 Details

Goodall JC, Ellis L, Yeo GS, Gaston JS (2007), “Does HLA-B27 influence the monocyte inflammatory response to lipopolysaccharide?” Rheumatology (Oxford) 46(2):232-7 Details

Gray J, Yeo G, Hung C, Keogh J, Clayton P, Banerjee K, McAulay A, O'Rahilly S, Farooqi IS (2007), “Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity.” Int J Obes (Lond) 31(2):359-64 Details

Heisler LK, Pronchuk N, Nonogaki K, Zhou L, Raber J, Tung L, Yeo GS, O'Rahilly S, Colmers WF, Elmquist JK, Tecott LH (2007), “Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation.” J Neurosci 27(26):6956-64 Details

Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis RK, Jimenez-Linan M, Blount M, Yeo GS, Lopez M, Seppänen-Laakso T, Ashcroft FM, Oresic M, Vidal-Puig A (2007), “PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.” PLoS Genet 3(4):e64 Details

Oswal A, Yeo GS (2007), “The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics.” Obes Rev 8(4):293-306 Details

2006

Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM, Yanovski JA, El Gharbawy A, Han JC, Tung YC, Hodges JR, Raymond FL, O'rahilly S, Farooqi IS (2006), “Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene.” Diabetes 55(12):3366-71 Details

Gray SL, Nora ED, Grosse J, Manieri M, Stoeger T, Medina-Gomez G, Burling K, Wattler S, Russ A, Yeo GS, Chatterjee VK, O'Rahilly S, Voshol PJ, Cinti S, Vidal-Puig A (2006), “Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice.” Diabetes 55(10):2669-77 Details

Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D, Shield J, Burren C, Ibrahim Z, Cheetham T, Swift P, Blackwood A, Hung CC, Wareham NJ, Froguel P, Millhauser GL, O'Rahilly S, Farooqi IS (2006), “A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance.” Cell Metab 3(2):135-40 Details

Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, Stanley MA, Coleman N (2006), “Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.” Proc Natl Acad Sci U S A 103(10):3822-7 Details

2005

Coll AP, Challis BG, López M, Piper S, Yeo GS, O'Rahilly S (2005), “Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids.” Diabetes 54(8):2269-76 Details

Lelliott CJ, López M, Curtis RK, Parker N, Laudes M, Yeo G, Jimenez-Liñan M, Grosse J, Saha AK, Wiggins D, Hauton D, Brand MD, O'Rahilly S, Griffin JL, Gibbons GF, Vidal-Puig A (2005), “Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis.” FASEB J 19(9):1108-19 Details

2004

Challis BG, Coll AP, Yeo GS, Pinnock SB, Dickson SL, Thresher RR, Dixon J, Zahn D, Rochford JJ, White A, Oliver RL, Millington G, Aparicio SA, Colledge WH, Russ AP, Carlton MB, O'Rahilly S (2004), “Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).” Proc Natl Acad Sci U S A 101(13):4695-700 Details

Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, Halsall D, Thresher RR, O'Rahilly S (2004), “The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin.” Endocrinology 145(10):4721-7 Details

Coll AP, Farooqi IS, Challis BG, Yeo GS, O'Rahilly S (2004), “Proopiomelanocortin and energy balance: insights from human and murine genetics.” J Clin Endocrinol Metab 89(6):2557-62 Details

Hung CC, Pirie F, Luan J, Lank E, Motala A, Yeo GS, Keogh JM, Wareham NJ, O'Rahilly S, Farooqi IS (2004), “Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits.” Diabetes 53(9):2461-6 Details

Laudes M, Barroso I, Luan J, Soos MA, Yeo G, Meirhaeghe A, Logie L, Vidal-Puig A, Schafer AJ, Wareham NJ, O'Rahilly S (2004), “Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes.” Diabetes 53(3):842-6 Details

O'Rahilly S, Yeo GS, Farooqi IS (2004), “Melanocortin receptors weigh in.” Nat Med 10(4):351-2 Details

Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, O'Rahilly S, Farooqi IS (2004), “A de novo mutation affecting human TrkB associated with severe obesity and developmental delay.” Nat Neurosci 7(11):1187-9 Details

2003

Donohoue PA, Tao YX, Collins M, Yeo GS, O'Rahilly S, Segaloff DL (2003), “Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female.” J Clin Endocrinol Metab 88(12):5841-5 Details

Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S (2003), “Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.” N Engl J Med 348(12):1085-95 Details

Farooqi IS, Yeo GS, O'Rahilly S (2003), “Binge eating as a phenotype of melanocortin 4 receptor gene mutations.” N Engl J Med 349(6):606-9; author reply 606-9 Details

Hung CC, Farooqi IS, Ong K, Luan J, Keogh JM, Pembrey M, Yeo GS, Dunger D, Wareham NJ, O' Rahilly S (2003), “Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations.” Diabetes 52(5):1288-91 Details

Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K, Schinner S, Sethi JK, Yeo G, Brand MD, Cortright RN, O'Rahilly S, Montague C, Vidal-Puig AJ (2003), “Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo.” Biochem J 373(Pt 1):155-65 Details

O'Rahilly S, Farooqi IS, Yeo GS, Challis BG (2003), “Minireview: human obesity-lessons from monogenic disorders.” Endocrinology 144(9):3757-64 Details

Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S (2003), “Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.” Hum Mol Genet 12(5):561-74 Details

Yeo GS, Siddle K (2003), “Attractin' more attention - new pieces in the obesity puzzle?” Biochem J 376(Pt 3):e7-8 Details

2002

Berger D, Barroso I, Soos M, Yeo G, Schafer AJ, O'Rahilly S, Whitehead JP (2002), “Genetic variants of insulin receptor substrate-1 (IRS-1) in syndromes of severe insulin resistance. Functional analysis of Ala513Pro and Gly1158Glu IRS-1.” Diabet Med 19(10):804-9 Details

Challis BG, Pritchard LE, Creemers JW, Delplanque J, Keogh JM, Luan J, Wareham NJ, Yeo GS, Bhattacharyya S, Froguel P, White A, Farooqi IS, O'Rahilly S (2002), “A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism.” Hum Mol Genet 11(17):1997-2004 Details

Challis BG, Yeo GS (2002), “Past, present and future strategies to study the genetics of body weight regulation.” Brief Funct Genomic Proteomic 1(3):290-304 Details

Crowley VE, Yeo GS, O'Rahilly S (2002), “Obesity therapy: altering the energy intake-and-expenditure balance sheet.” Nat Rev Drug Discov 1(4):276-86 Details

Mulligan C, Rochford J, Denyer G, Stephens R, Yeo G, Freeman T, Siddle K, O'Rahilly S (2002), “Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1.” J Biol Chem 277(45):42480-7 Details

2000

Challis BG, Yeo GS, Farooqi IS, Luan J, Aminian S, Halsall DJ, Keogh JM, Wareham NJ, O'Rahilly S (2000), “The CART gene and human obesity: mutational analysis and population genetics.” Diabetes 49(5):872-5 Details

Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S (2000), “Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency.” J Clin Invest 106(2):271-9 Details

Yeo GS, Farooqi IS, Challis BG, Jackson RS, O'Rahilly S (2000), “The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models.” QJM 93(1):7-14 Details

1999

Elgar G, Clark MS, Meek S, Smith S, Warner S, Edwards YJ, Bouchireb N, Cottage A, Yeo GS, Umrania Y, Williams G, Brenner S (1999), “Generation and analysis of 25 Mb of genomic DNA from the pufferfish Fugu rubripes by sequence scanning.” Genome Res 9(10):960-71 Details

1998

Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S (1998), “A frameshift mutation in MC4R associated with dominantly inherited human obesity.” Nat Genet 20(2):111-2 Details

1997

Yeo GS, Elgar G, Sandford R, Brenner S (1997), “Cloning and sequencing of complement component C9 and its linkage to DOC-2 in the pufferfish Fugu rubripes.” Gene 200(1-2):203-11 Details